[Use of the mucoregulator ascoril for respiratory diseases].
N M Shmeleva
Index: Ter. Arkh. 84(10) , 86-90, (2012)
Full Text: HTML
Abstract
The paper deals with the use of the combined mucoregulatory drug ascoril in pulmonological care. Due to its multicomponent composition, the drug has mucoregulatory properties that combine a bronchodilator effect and an ability to dilute sputum and to synthesize the surfactant. The mechanism of action of each ascoril component is analyzed; the results of basic experimental and clinical studies on the use of the drug are given. A wide range of indications, such as respiratory system diseases, for ascoril use is demonstrated.
Related Compounds
Related Articles:
2013-03-10
[Int. J. Pharm. 445(1-2) , 93-8, (2013)]
2015-03-15
[Int. J. Pharm. 481(1-2) , 132-9, (2015)]
Predicting prognosis in idiopathic pulmonary fibrosis.
2010-07-01
[Sarcoidosis Vasc. Diffuse Lung Dis. 27(2) , 85-95, (2010)]
Contaminations of herbal products determined by NMR fingerprint.
2010-09-01
[Nat. Prod. Res. 24(14) , 1325-9, (2010)]
2010-10-01
[J. Ultrasound Med. 29(10) , 1503-6, (2010)]